A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer-Reference-Cited by-同舟云学术

A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer

Published:2013-01-26 Issue:4 Volume:71 Page:973-979
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sasaki Takashi,Isayama Hiroyuki,Nakai Yousuke,Ito Yukiko,Yasuda Ichiro,Toda Nobuo,Kogure Hirofumi,Hanada Keiji,Maguchi Hiroyuki,Sasahira Naoki,Kamada Hideki,Mukai Tsuyoshi,Okabe Yoshihiro,Hasebe Osamu,Maetani Iruru,Koike Kazuhiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2090-4.pdf

Reference13 articles.

1. Vital Statistics Japan (Ministry of Health, Labour and Welfare). http://ganjoho.jp/professional/statistics/statistics.html

2. Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C (2004) Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 91:1769–1774

3. Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, Nematollahi M, Pond GR, Zhang J, Moore MJ (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23:2332–2338

4. Furuse J, Okusaka T, Boku N, Ohkawa S, Sawaki A, Masumoto T, Funakoshi A (2008) S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study. Cancer Chemother Pharmacol 62:849–855

5. Sasaki T, Isayama H, Yashima Y, Yagioka H, Kogure H, Arizumi T, Togawa O, Matsubara S, Ito Y, Nakai Y, Sasahira N, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M (2009) S-1 monotherapy in patients with advanced biliary tract cancer. Oncology 77:71–74

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08

2. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF);Liver International;2024-07-05

3. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma;BMC Gastroenterology;2024-05-20

4. 21Management of Intrahepatic and Extrahepatic Cholangiocarcinoma;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

5. Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment;Digestive and Liver Disease;2023-09